BBC News
BBC News
A pair of cancer drugs can shrink tumours in nearly 60% of people with advanced melanoma, a new trial has suggested. An international trial on 945 patients found treatment with ipilimumab and nivolumab stopped the cancer advancing for nearly a year in ...
High Prices for Drugs Attacked at Meeting Wall Street Journal
Opdivo (nivolumab) Demonstrates Superior Survival Compared to Standard of ... MarketWatch
Nivolumab Significantly Improves Outcomes in Advanced Melanoma Cancer Therapy Advisor
Yahoo News
all 42 news articles »
from @ Health and Medical News http://ift.tt/1KwZBdZ
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
